C. Bracco

CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma.

G. Matullo, M. Papotti, F. Grosso, 2016, Cancer letters.

A founder MLH1 mutation in Lynch syndrome families from Piedmont, Italy, is associated with an increased risk of pancreatic tumours and diverse immunohistochemical patterns

T. Venesio, B. Pasini, G. Mandrile, 2014, Familial Cancer.

Inhibition of Src Impairs the Growth of Met-Addicted Gastric Tumors

P. Elvin, L. Trusolino, A. Bertotti, 2010, Clinical Cancer Research.

CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma.

G. Matullo, M. Papotti, F. Grosso, 2016, Cancer letters.

A founder MLH1 mutation in Lynch syndrome families from Piedmont, Italy, is associated with an increased risk of pancreatic tumours and diverse immunohistochemical patterns

T. Venesio, B. Pasini, G. Mandrile, 2014, Familial Cancer.

Inhibition of Src Impairs the Growth of Met-Addicted Gastric Tumors

P. Elvin, L. Trusolino, A. Bertotti, 2010, Clinical Cancer Research.

CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma.

G. Matullo, A. Aspesi, E. Casalone, 2016, Cancer letters.